Median Age of COVID-19 Cases Declined in May to August in U.S.
FRIDAY, Sept. 25, 2020 (HealthDay News) — From May to August 2020, there was a decrease in the median age of COVID-19 cases in the United States, according to research published in the Sept. 23 early-release issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.
One-Fifth of Those With SARS-CoV-2 Infection Asymptomatic
FRIDAY, Sept. 25, 2020 (HealthDay News) — About one-fifth of individuals with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection are asymptomatic and their viral load is comparable to that of patients with mild symptoms, according to a study published online Sept. 22 in Thorax.
Fertility Treatment Cancellations Due to COVID-19 Impact Mental Health
FRIDAY, Sept. 25, 2020 (HealthDay News) — Fertility treatment suspensions due to the COVID-19 pandemic have had a considerable negative impact on women’s mental health and quality of life, according to a study published online Sept. 18 in PLOS ONE.
Chinese Company Says Its COVID-19 Vaccine Should Be Available in U.S. in Early 2021
THURSDAY, Sept. 24, 2020 (HealthDay News) — A Chinese pharmaceutical company claims its COVID-19 vaccine should available by early next year for distribution in the United States and other countries.
Public Awareness Low for Invasive Fungal Diseases
THURSDAY, Sept. 24, 2020 (HealthDay News) — More than two-thirds of individuals have never heard of any of six invasive fungal diseases, according to research published in the Sept. 25 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.
Measures of Central Adiposity Linked to All-Cause Mortality
THURSDAY, Sept. 24, 2020 (HealthDay News) — Several indices of central adiposity, including waist circumference and body adiposity index, are associated with an increased risk for all-cause mortality, according to a review published online Sept. 23 in The BMJ.
Guidelines Updated for Managing Dyslipidemia to Cut CVD Risk
THURSDAY, Sept. 24, 2020 (HealthDay News) — In a synopsis of the 2020 updated clinical practice guideline from the U.S. Department of Veterans Affairs and the U.S. Department of Defense, published online Sept. 22 in the Annals of Internal Medicine, recommendations are presented for the management of dyslipidemia to reduce cardiovascular disease (CVD) risk.
Clinical Practice Guideline Synopsis
Evidence Review (subscription or payment may be required)
Editorial (subscription or payment may be required)
As Flu Season Approaches, Clinicians Brace for Potential ‘Twindemic’
AMI, Stroke Risk Elevated for Women With Preeclampsia Within 20 Years 
Sexual Dysfunction Common Among Young Women With Cancer 
Self-Cut Mesh Noninferior for Pelvic Organ Prolapse Procedure 
How PCOS Diagnosis Is Communicated May Affect Later Well-Being 
Mental Health Concerns Increasingly Addressed at Primary Care Visits 
Long-Term Air Pollution Exposure Tied to Higher Depression, Anxiety Risk 
Social Isolation, Loneliness Increase Risk for New Heart Failure 
Uncomplicated Urinary Tract Infections Put Significant Burden on U.S. Women 
